ZIOPHARM Oncology Inc Key Financial Ratios and Statistics
Financial Ratios and Key Statistics FYE 31-Dec
| Profitability | 2007 | Leverage | 2007 |
| Net Inc/Comm Equity | -0.38 | Total Liab/Total Assets | 0.17 |
| Net Inc/Total Assets | -0.72 | Total Liab/Inv Cap | 0.21 |
| Net Inc/Inv Cap | -0.87 | Total Liab/Comm Equity | 0.09 |
| Pretax Inc/Net Sales | NA | Interest Coverage Ratio | NA |
| Net Inc/Net Sales | NA | Curr Debt/Equity | NA |
| Cash Flow/Net Sales | NA | LTD/Equity | NA |
| SG&A/NetSales | NA | Total Debt/Equity | NA |
| Asset Utilization | Liquidity | ||
| Net Receivables Turnover | NA | Quick Ratio | 5.63 |
| Inventory Turnover | NA | Current Ratio | 5.63 |
| Inventory Day Sales | NA | Net Rec/Curr Assets | NA |
| Net Sales/Work Cap | NA | Inv/Curr Assets | NA |
| Net Sales/PP&E | NA |
ZIOPHARM Oncology Inc Key Financial Ratios and Statistics